Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1981 4
1982 6
1983 2
1984 2
1985 7
1986 4
1987 10
1988 6
1989 8
1990 10
1991 12
1992 9
1993 15
1994 8
1995 11
1996 9
1997 13
1998 10
1999 5
2000 13
2001 12
2002 7
2003 6
2004 9
2005 13
2006 18
2007 11
2008 16
2009 10
2010 15
2011 14
2012 5
2013 17
2014 21
2015 18
2016 11
2017 14
2018 15
2019 18
2020 23
2021 10
2022 14
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

435 results

Results by year

Filters applied: . Clear all
Page 1
γδ T cells: origin and fate, subsets, diseases and immunotherapy.
Hu Y, Hu Q, Li Y, Lu L, Xiang Z, Yin Z, Kabelitz D, Wu Y. Hu Y, et al. Among authors: kabelitz d. Signal Transduct Target Ther. 2023 Nov 22;8(1):434. doi: 10.1038/s41392-023-01653-8. Signal Transduct Target Ther. 2023. PMID: 37989744 Free PMC article. Review.
Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Kabelitz D, et al. Cell Mol Immunol. 2020 Sep;17(9):925-939. doi: 10.1038/s41423-020-0504-x. Epub 2020 Jul 22. Cell Mol Immunol. 2020. PMID: 32699351 Free PMC article. Review.
Editorial: γδ T Cells in Cancer.
Coffelt SB, Kabelitz D, Silva-Santos B, Kuball J, Born W, Bank I. Coffelt SB, et al. Among authors: kabelitz d. Front Immunol. 2020 Nov 20;11:602411. doi: 10.3389/fimmu.2020.602411. eCollection 2020. Front Immunol. 2020. PMID: 33329597 Free PMC article. No abstract available.
Preface.
Kabelitz D. Kabelitz D. Recent Pat Antiinfect Drug Discov. 2018;13(1):2. doi: 10.2174/1574891X1301180927103705. Recent Pat Antiinfect Drug Discov. 2018. PMID: 30424718
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer.
Xu Y, Xiang Z, Alnaggar M, Kouakanou L, Li J, He J, Yang J, Hu Y, Chen Y, Lin L, Hao J, Li J, Chen J, Li M, Wu Q, Peters C, Zhou Q, Li J, Liang Y, Wang X, Han B, Ma M, Kabelitz D, Xu K, Tu W, Wu Y, Yin Z. Xu Y, et al. Among authors: kabelitz d. Cell Mol Immunol. 2021 Feb;18(2):427-439. doi: 10.1038/s41423-020-0515-7. Epub 2020 Sep 16. Cell Mol Immunol. 2021. PMID: 32939032 Free PMC article.
Editorial: Extracellular vesicles in cancer immunosurveillance.
Moloudizargari M, Asghari MH, Jørgensen MM, Reiter RJ, Kabelitz D. Moloudizargari M, et al. Among authors: kabelitz d. Front Immunol. 2022 Aug 4;13:993967. doi: 10.3389/fimmu.2022.993967. eCollection 2022. Front Immunol. 2022. PMID: 35990697 Free PMC article. No abstract available.
Immunology Education Without Borders.
Kabelitz D, Letarte M, Gray CM. Kabelitz D, et al. Front Immunol. 2019 Aug 28;10:2012. doi: 10.3389/fimmu.2019.02012. eCollection 2019. Front Immunol. 2019. PMID: 31555265 Free PMC article. Review.
Regulatory functions of γδ T cells.
Peters C, Kabelitz D, Wesch D. Peters C, et al. Among authors: kabelitz d. Cell Mol Life Sci. 2018 Jun;75(12):2125-2135. doi: 10.1007/s00018-018-2788-x. Epub 2018 Mar 8. Cell Mol Life Sci. 2018. PMID: 29520421 Review.
435 results